ct1812

Small moleculeexperimental

Clinical trial activity

13 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
7
Phase 3
0
Phase 4
0

Earliest trial started Sep 1, 2015 (NCT02570997)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ct1812

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05893537Phase 2Jun 16, 2023Cognition Therapeutics
NCT05531656Phase 2Dec 31, 2022Alzheimer's Clinical Trial Consortium (ACTC), Cognition Therapeutics, National Institute on Aging (NIA)
NCT05225415Phase 2Jun 22, 2022Cognition Therapeutics, National Institute on Aging (NIA)
NCT05248672Phase 1Mar 2, 2022Cognition Therapeutics
NCT05225389Phase 1Jan 10, 2022Cognition Therapeutics, National Institute on Aging (NIA)
NCT04735536Phase 2Jul 30, 2020Brain Research Center, Amsterdam, Cognition Therapeutics
NCT03507790Phase 2Jul 31, 2018Cognition Therapeutics
NCT03522129Phase 1May 16, 2018Cognition Therapeutics, University of Pennsylvania
NCT03493282Phase 1/Phase 2 (Phase 2)Apr 20, 2018Cognition Therapeutics, Yale University
NCT03716427Phase 1Nov 10, 2016Cognition Therapeutics
NCT02907567Phase 1/Phase 2 (Phase 2)Sep 1, 2016Austin Health, Cognition Therapeutics
NCT02570997Phase 1Sep 1, 2015Cognition Therapeutics, Nucleus Network Ltd
NCT06961760N/ACognition Therapeutics
Showing 13 of 13 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cognition TherapeuticsFor profit131332015
National Institute on Aging (NIA)Government3022022
Alzheimer's Clinical Trial Consortium (ACTC)Academic/Hospital1012022
Austin HealthAcademic/Hospital1012016
Brain Research Center, AmsterdamAcademic/Hospital1012020
Nucleus Network LtdFor profit1012015
University of PennsylvaniaAcademic/Hospital1012018
Yale UniversityAcademic/Hospital1012018
8 organizations
Page 1 / 1